XBiotech Announces Enrollment Completion, Positive Findings for Bermekimab in Pancreatic Cancer Study

World News: . []

AUSTIN Texas May 02 2019 GLOBE NEWSWIRE -- LINK  Inc NASDAQ XBIT announced today enrollment of the final LINK  into its Phase I study evaluating bermekimab in patients with advanced pancreatic adenocarcinoma and LINK  The study i s being...

More news and information about XBiotech Inc.

Published By:

Globe Newswire: 13:15 GMT Thursday 2nd May 2019

Published: .

Search for other references to "xbiotech" on SPi News


Previous StoryNext Story

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 07519380.
Privacy Policy | Terms and Conditions | Contact Us